Family Office Tech Investors

Dolby Family Ventures

Dolby Family Ventures selectively invests private capital in passionate tech entrepreneurs.

Venture Investor Overview

Venture Investor
Dolby Family Ventures
Status
Active
Investor Type
Family Office
Activity Level
70 transactions
Funds Raised
Unknown
Industry Focus
Alternative Energy
Artificial Intelligence
Biopharmaceutical
Digital Media & VR & AR
Electronics
Engineering
Healthcare IT
Healthcare Services
Life Sciences
Manufacturing
Medical Devices & Instruments
Robotics
Security
Software
Transportation

Contact Information

Contact
David Dolby
Title
Managing Partner
Mailing Address
999 Brannan St. 114
San Francisco, CA 94103
USA
Phone
(415) 449-1005
Website
www.dolbyventures.com
Email Address
[email protected]

Background Information

Overview
Dolby Family Ventures is an early stage venture firm focused on building great technology companies. We partner with best-in-class innovators and strong investment syndicate partners at the seed stage of a company's development. Unlike many seed investors, we intend to continue to invest across future rounds in our successful portfolio companies.
Profile
Dolby Family Ventures LinkedIn Company Profile
Social Media
Dolby Family Ventures Company Twitter Account
Company News
Dolby Family Ventures News
Facebook
Dolby Family Ventures on Facebook
YouTube
Dolby Family Ventures on YouTube
Last Transaction
10/23/2024

Transaction History

Our records indicate that Dolby Family Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Calicat
10/23/2024
$3,000,000
California Catalysts
10/23/2024
$3,000,000
Vandria
8/21/2024
Unknown
NeuroTherapia
8/6/2024
$12,300,000
Montara Therapeutics
7/30/2024
$8,000,000
Progentos Therapeutics
5/20/2024
$65,000,000
LeoLabs
2/12/2024
$29,000,000
Motif Neuro
1/24/2024
$18,750,000
Cognitive Space
10/17/2023
$4,000,000
Mojo Vision
10/12/2023
$43,500,000
Sharrow Marine
6/21/2023
$30,000,000
Paradromics
5/18/2023
$33,000,000
Genemod
5/3/2023
$4,500,000
Therini Bio
4/27/2023
$36,000,000
Mojo Vision
4/5/2023
$22,400,000
Switch Therapeutics
3/14/2023
$52,000,000
QurAlis
3/9/2023
$88,000,000
Cerevance
2/13/2023
$51,000,000
Atomos Space
1/28/2023
$16,000,000
Cajal Neuroscience
11/29/2022
$96,000,000
Bionaut Labs
11/28/2022
$43,000,000
MedCrypt
11/1/2022
$25,000,000
Canaery
7/1/2022
$4,000,000
OKAPI Orbits
6/13/2022
$5,750,000
Diamond Age
3/10/2022
$50,000,000
Ursa Major
12/9/2021
$85,000,000
Cala Health
11/18/2021
$77,000,000
DigiLens
11/6/2021
Unknown
TripleBlind
10/19/2021
$24,000,000
Delix Therapeutics
9/28/2021
$70,000,000
Paradromics
7/26/2021
$20,000,000
Therini Bio
5/11/2021
$17,000,000
TripleBlind
3/8/2021
$8,200,000
NeuroTherapia
9/28/2020
$8,800,000
Libra Therapeutics
9/24/2020
$29,000,000
Atomwise
8/12/2020
$123,000,000
Cerevance
7/22/2020
$20,000,000
QurAlis
5/15/2020
$42,000,000
Mojo Vision
4/30/2020
$51,000,000
Tech Matters
4/3/2020
$1,700,000
EnClear Therapies
2/21/2020
$10,000,000
Atmosic Technologies
12/20/2019
$28,500,000
MedaRed
7/9/2019
$6,500,000
Phylagen
2/15/2019
$14,000,000
Ultrahaptics
12/5/2018
$45,000,000
Mojo Vision
11/15/2018
$50,000,000
System1 Biosciences
9/13/2018
$25,000,000
Vium
6/22/2018
$24,000,000
Paradromics
6/12/2018
$7,000,000
Zebra Medical Vision
6/8/2018
$30,000,000
Cortexyme
6/1/2018
$76,000,000
Tempo Automation
4/17/2018
$20,000,000
Atomwise
3/8/2018
$45,000,000
Ultrahaptics
5/4/2017
$23,000,000
Echo Microscope
4/4/2017
$7,500,000
DigiLens
1/20/2017
$22,000,000
Tetra Discovery Partners
11/30/2016
$5,000,000
Vium
6/3/2016
$33,000,000
Zebra Medical Vision
5/26/2016
$12,000,000
Yumanity
2/11/2016
$45,000,000
Eyefluence
11/11/2015
$14,000,000
8i
10/15/2015
$13,500,000
AltspaceVR
7/29/2015
$10,300,000
Cognition Therapeutics
7/22/2015
$12,000,000
ZOZI
7/1/2015
$30,000,000
August Home
3/25/2015
$38,000,000
New Matter
2/11/2015
$6,500,000
PharmatrophiX
10/7/2014
$5,500,000
Cortexyme
10/6/2014
$1,000,000
AltspaceVR
9/12/2014
$5,200,000

 

Investor Contacts

Title
Name
Email & Social
Managing Partner
David Dolby
  David Dolby LinkedIn Profile  David Dolby Twitter Account  David Dolby News  David Dolby on Facebook
Partner
Andrew Krowne
  Andrew Krowne LinkedIn Profile  Andrew Krowne Twitter Account  Andrew Krowne News  Andrew Krowne on Facebook
Partner
Pascal Levensohn
  Pascal Levensohn LinkedIn Profile  Pascal Levensohn Twitter Account  Pascal Levensohn News  Pascal Levensohn on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

Dolby Family Ventures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
8i
AltspaceVR
Atmosic Technologies
Atomos Space
Atomwise
August Home
Bionaut Labs
Cajal Neuroscience
Cala Health
Calicat
California Catalysts
Canaery
Cerevance
Cognition Therapeutics
Cognitive Space
Cortexyme
Delix Therapeutics
Diamond Age
DigiLens
Echo Microscope
EnClear Therapies
Eyefluence
Genemod
LeoLabs
Libra Therapeutics
MedaRed
MedCrypt
Mojo Vision
Montara Therapeutics
Motif Neuro
NeuroTherapia
New Matter
OKAPI Orbits
Paradromics
PharmatrophiX
Phylagen
Progentos Therapeutics
QurAlis
Sharrow Marine
Switch Therapeutics
System1 Biosciences
Tech Matters
Tempo Automation
Tetra Discovery Partners
Therini Bio
TripleBlind
Ultrahaptics
Ursa Major
Vandria
Vium
Yumanity
Zebra Medical Vision
ZOZI

 

 

 

 

Browse more family wealth tech investors:

DNS Capital | Dolby Trust

 

Share this article

 

About Our Directory of Family Offices

Our family office, trust and foundation data comes from VentureDeal.com, a market leader in family office transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.